id	sid	eid	entity	type
cpe-7525	1	1	europe	LOC
cpe-7525	2	1	europe	LOC
cpe-7525	3	1	tania m. lincoln 1	PERSON
cpe-7525	3	2	2	CARDINAL
cpe-7525	3	3	1	CARDINAL
cpe-7525	3	4	university of hamburg	ORG
cpe-7525	3	5	hamburg	GPE
cpe-7525	3	6	germany	GPE
cpe-7525	4	1	2	CARDINAL
cpe-7525	4	2	philipps-university of marburg	ORG
cpe-7525	4	3	marburg	GPE
cpe-7525	4	4	germany	GPE
cpe-7525	5	1	europe	LOC
cpe-7525	5	2	2021	DATE
cpe-7525	5	3	3(3	CARDINAL
cpe-7525	5	4	2021	CARDINAL
cpe-7525	5	5	tania m. lincoln	PERSON
cpe-7525	5	6	universität hamburg	GPE
cpe-7525	5	7	und psychotherapie	PERSON
cpe-7525	5	8	von-melle-park 5,	PERSON
cpe-7525	5	9	20146	DATE
cpe-7525	5	10	hamburg	GPE
cpe-7525	5	11	germany	GPE
cpe-7525	7	1	covid-19	DATE
cpe-7525	7	2	europe	LOC
cpe-7525	9	1	european	NORP
cpe-7525	9	2	70%	PERCENT
cpe-7525	10	1	infectiousness	ORG
cpe-7525	10	2	about 90%	PERCENT
cpe-7525	12	1	freeman et al.	PERSON
cpe-7525	12	2	2020	DATE
cpe-7525	12	3	2020	DATE
cpe-7525	12	4	2021	CARDINAL
cpe-7525	12	5	2021	CARDINAL
cpe-7525	13	1	2020	DATE
cpe-7525	13	2	allington et al.	PERSON
cpe-7525	13	3	2021	CARDINAL
cpe-7525	13	4	ebrahimi et al.	PERSON
cpe-7525	13	5	2021	CARDINAL
cpe-7525	13	6	murphy et al.	PERSON
cpe-7525	13	7	2021	DATE
cpe-7525	13	8	2021	CARDINAL
cpe-7525	13	9	covid-19	PRODUCT
cpe-7525	14	1	three	CARDINAL
cpe-7525	15	1	ebrahimi et al.	PERSON
cpe-7525	15	2	2021	CARDINAL
cpe-7525	15	3	freeman	PERSON
cpe-7525	15	4	4.0	CARDINAL
cpe-7525	15	5	4.0	CARDINAL
cpe-7525	16	1	https://crossmark.crossref.org/dialog/?doi=10.32872/cpe.7525&domain=pdf&date_stamp=2021-09-30 https://cpe.psychopen.eu/	PERSON
cpe-7525	17	1	2020	DATE
cpe-7525	17	2	lincoln et al.	ORG
cpe-7525	17	3	2021	CARDINAL
cpe-7525	17	4	murphy et al.	PERSON
cpe-7525	17	5	2021	CARDINAL
cpe-7525	17	6	allington et al.	PERSON
cpe-7525	17	7	2021	CARDINAL
cpe-7525	17	8	freeman et al.	PERSON
cpe-7525	17	9	2020	DATE
cpe-7525	17	10	murphy et al.	PERSON
cpe-7525	17	11	2021	DATE
cpe-7525	17	12	freeman et al.	PERSON
cpe-7525	17	13	2020	DATE
cpe-7525	17	14	neumann	ORG
cpe-7525	17	15	2020	DATE
cpe-7525	18	1	covid-19	PERSON
cpe-7525	18	2	allington et al.	PERSON
cpe-7525	18	3	2021	CARDINAL
cpe-7525	18	4	2021	CARDINAL
cpe-7525	18	5	ebrahimi et al.	PERSON
cpe-7525	18	6	2021	CARDINAL
cpe-7525	28	1	five	CARDINAL
cpe-7525	29	1	1	CARDINAL
cpe-7525	29	2	german	NORP
cpe-7525	29	3	cosmo	PERSON
cpe-7525	29	4	cosmo-konsortium	LAW
cpe-7525	29	5	2021	DATE
cpe-7525	29	6	only about half	CARDINAL
cpe-7525	29	7	half	CARDINAL
cpe-7525	38	1	prochaska	PERSON
cpe-7525	38	2	di clemente’s	PERSON
cpe-7525	38	3	1986	DATE
cpe-7525	39	1	europe	LOC
cpe-7525	40	1	2	CARDINAL
cpe-7525	40	2	europe 2021	DATE
cpe-7525	40	3	3(3	CARDINAL
cpe-7525	40	4	2	CARDINAL
cpe-7525	40	5	one	CARDINAL
cpe-7525	45	1	rief & joormann	ORG
cpe-7525	45	2	2019	DATE
cpe-7525	47	1	one	CARDINAL
cpe-7525	51	1	3	CARDINAL
cpe-7525	53	1	100%	PERCENT
cpe-7525	56	1	4.	CARDINAL
cpe-7525	57	1	one	CARDINAL
cpe-7525	58	1	1 to 100 percent	PERCENT
cpe-7525	63	1	lincoln &	ORG
cpe-7525	63	2	3	CARDINAL
cpe-7525	63	3	europe 2021	DATE
cpe-7525	63	4	3(3	CARDINAL
cpe-7525	66	1	covid-19	ORG
cpe-7525	66	2	2021	CARDINAL
cpe-7525	68	1	two	CARDINAL
cpe-7525	73	1	prochaska	ORG
cpe-7525	73	2	di clemente’s	PERSON
cpe-7525	73	3	1986	DATE
cpe-7525	73	4	one	CARDINAL
cpe-7525	74	1	5	CARDINAL
cpe-7525	74	2	one	CARDINAL
cpe-7525	81	1	europe	LOC
cpe-7525	82	1	4	CARDINAL
cpe-7525	82	2	europe 2021	DATE
cpe-7525	82	3	3(3	CARDINAL
cpe-7525	86	1	allington	PERSON
cpe-7525	86	2	d.	NORP
cpe-7525	86	3	b.	PERSON
cpe-7525	86	4	s.	PERSON
cpe-7525	86	5	dhavan, n., & rubin	PERSON
cpe-7525	86	6	j.	PERSON
cpe-7525	86	7	2021	CARDINAL
cpe-7525	87	1	covid-19	ORG
cpe-7525	88	1	1763-1769	DATE
cpe-7525	89	1	s. a.	PERSON
cpe-7525	89	2	faria de moura villela	PERSON
cpe-7525	89	3	e.	PERSON
cpe-7525	89	4	siau	PERSON
cpe-7525	89	5	c. s.	PERSON
cpe-7525	89	6	chen	PERSON
cpe-7525	89	7	w. s.	PERSON
cpe-7525	89	8	s.	PERSON
cpe-7525	89	9	hasan	PERSON
cpe-7525	89	10	m. t.	PERSON
cpe-7525	90	1	ditekemena	ORG
cpe-7525	90	2	j. d.	PERSON
cpe-7525	90	3	amodan	GPE
cpe-7525	90	4	m. c.	PERSON
cpe-7525	90	5	dolo, h.	ORG
cpe-7525	90	6	j. n.	PERSON
cpe-7525	90	7	w. y.,	PERSON
cpe-7525	90	8	r.	NORP
cpe-7525	90	9	2021	CARDINAL
cpe-7525	91	1	covid-19	PRODUCT
cpe-7525	92	1	9(5	CARDINAL
cpe-7525	92	2	article 515	LAW
cpe-7525	93	1	https://doi.org/10.3390/vaccines9050515 cosmo-konsortium	PERSON
cpe-7525	94	1	2021	CARDINAL
cpe-7525	95	1	zusammenfassung und empfehlungen wellen	PERSON
cpe-7525	95	2	48	CARDINAL
cpe-7525	95	3	51	CARDINAL
cpe-7525	96	1	https://projekte.uni-erfurt.de/cosmo2020/web/summary/48-51/ ebrahimi	PERSON
cpe-7525	96	2	o. v.	PERSON
cpe-7525	96	3	johnson	PERSON
cpe-7525	96	4	m. s.	PERSON
cpe-7525	96	5	s., amundsen	PERSON
cpe-7525	96	6	o. m.	PERSON
cpe-7525	96	7	halsøy	PERSON
cpe-7525	96	8	a., skjerdingstad	PERSON
cpe-7525	96	9	n., & johnson	ORG
cpe-7525	96	10	2021	CARDINAL
cpe-7525	97	1	covid-19	PERSON
cpe-7525	98	1	9	CARDINAL
cpe-7525	99	1	https://doi.org/10.3389/fpubh.2021.700213 freeman	PERSON
cpe-7525	99	2	d.	NORP
cpe-7525	99	3	b. s.	PERSON
cpe-7525	99	4	chadwick	GPE
cpe-7525	99	5	vaccari	PERSON
cpe-7525	99	6	c.	PERSON
cpe-7525	99	7	f.	PERSON
cpe-7525	99	8	lewandowsky	PERSON
cpe-7525	99	9	s.	PERSON
cpe-7525	99	10	s.	PERSON
cpe-7525	99	11	innocenti	ORG
cpe-7525	99	12	s.	PERSON
cpe-7525	99	13	a.	PERSON
cpe-7525	99	14	yu, l.-m.	PERSON
cpe-7525	99	15	mcshane, h., pollard	ORG
cpe-7525	99	16	a. j., & lambe	PERSON
cpe-7525	99	17	s. (2020	ORG
cpe-7525	100	1	covid-19	PERSON
cpe-7525	100	2	uk	GPE
cpe-7525	100	3	oxford	NORP
cpe-7525	103	1	holzmann-littig	ORG
cpe-7525	103	2	m. c.	PERSON
cpe-7525	103	3	kranke	PERSON
cpe-7525	103	4	popp	PERSON
cpe-7525	103	5	m.	PERSON
cpe-7525	103	6	f.	PERSON
cpe-7525	103	7	j.	GPE
cpe-7525	103	8	allwang	GPE
cpe-7525	103	9	c., frank	GPE
cpe-7525	103	10	meerpohl	PERSON
cpe-7525	103	11	j. j.	PERSON
cpe-7525	103	12	haller	GPE
cpe-7525	103	13	b., & schmaderer	ORG
cpe-7525	103	14	2021	CARDINAL
cpe-7525	104	1	covid-19	DATE
cpe-7525	104	2	germany	GPE
cpe-7525	105	1	9(7	CARDINAL
cpe-7525	105	2	article 777	LAW
cpe-7525	106	1	https://doi.org/10.3390/vaccines9070777 lincoln	PERSON
cpe-7525	106	2	t. m.	PERSON
cpe-7525	106	3	b.	PERSON
cpe-7525	106	4	f.	PERSON
cpe-7525	106	5	s.	GPE
cpe-7525	106	6	kingston	GPE
cpe-7525	106	7	j., morris	ORG
cpe-7525	106	8	e., & ellett	ORG
cpe-7525	106	9	l.	PERSON
cpe-7525	106	10	2021	CARDINAL
cpe-7525	109	1	murphy	PERSON
cpe-7525	109	2	j.	PERSON
cpe-7525	109	3	f.	PERSON
cpe-7525	109	4	r. p.	PERSON
cpe-7525	109	5	shevlin	GPE
cpe-7525	109	6	m., mcbride	PERSON
cpe-7525	109	7	hartman	PERSON
cpe-7525	109	8	t. k.	PERSON
cpe-7525	109	9	mckay	GPE
cpe-7525	109	10	r.	NORP
cpe-7525	109	11	bennett	PERSON
cpe-7525	109	12	mason	GPE
cpe-7525	109	13	l.	GPE
cpe-7525	109	14	gibson-miller	PERSON
cpe-7525	109	15	j., levita	GPE
cpe-7525	109	16	l.	GPE
cpe-7525	109	17	martinez	GPE
cpe-7525	109	18	a. p.	PERSON
cpe-7525	109	19	t. v. a.	PERSON
cpe-7525	109	20	t., & hyland	ORG
cpe-7525	109	21	2021	CARDINAL
cpe-7525	110	1	covid-19	ORG
cpe-7525	110	2	ireland	GPE
cpe-7525	110	3	the united kingdom	GPE
cpe-7525	111	1	12(1	CARDINAL
cpe-7525	111	2	article 29	LAW
cpe-7525	112	1	lincoln &	ORG
cpe-7525	112	2	5	CARDINAL
cpe-7525	112	3	europe 2021	DATE
cpe-7525	112	4	3(3	CARDINAL
cpe-7525	113	1	https://doi.org/10.3390/vaccines9070777 https://doi.org/10.21203/rs.3.rs-787170/v1 https://doi.org/10.1038/s41467-020-20226-9	PERSON
cpe-7525	113	2	neumann	ORG
cpe-7525	113	3	s.	GPE
cpe-7525	113	4	varghese	PRODUCT
cpe-7525	113	5	n. e.	PERSON
cpe-7525	113	6	sabat, i.	ORG
cpe-7525	113	7	barros, p. p.	GPE
cpe-7525	113	8	brouwer	PERSON
cpe-7525	113	9	w., van exel	PERSON
cpe-7525	113	10	j.	PERSON
cpe-7525	113	11	j., & stargardt	ORG
cpe-7525	113	12	2020	DATE
cpe-7525	116	1	european	NORP
cpe-7525	116	2	covid-19	GPE
cpe-7525	117	1	the european journal of health economics	ORG
cpe-7525	117	2	21(7	CARDINAL
cpe-7525	117	3	977	CARDINAL
cpe-7525	117	4	cortaredona	PERSON
cpe-7525	117	5	s.	PERSON
cpe-7525	117	6	launay	PERSON
cpe-7525	117	7	j., verger, p.	ORG
cpe-7525	117	8	beck, f.	PERSON
cpe-7525	117	9	legleye	PERSON
cpe-7525	117	10	s.	GPE
cpe-7525	117	11	l’haridon	GPE
cpe-7525	117	12	léger	PERSON
cpe-7525	117	13	d., & ward	ORG
cpe-7525	117	14	j. k.	PERSON
cpe-7525	117	15	2020	DATE
cpe-7525	118	1	covid-19	ORG
cpe-7525	119	1	20(7	DATE
cpe-7525	119	2	769	CARDINAL
cpe-7525	120	1	https://doi.org/10.1016/s1473-3099(20)30426-6 prochaska	PERSON
cpe-7525	120	2	j. o., & diclemente	ORG
cpe-7525	120	3	c. c.	PERSON
cpe-7525	120	4	1986	DATE
cpe-7525	122	1	w. r. miller & n. heather	ORG
cpe-7525	122	2	3–27	CARDINAL
cpe-7525	124	1	w.	PERSON
cpe-7525	124	2	2021	CARDINAL
cpe-7525	125	1	covid-19	PRODUCT
cpe-7525	126	1	2(4	CARDINAL
cpe-7525	126	2	article e210804	PERSON
cpe-7525	127	1	w., & joormann	ORG
cpe-7525	127	2	j. (	PERSON
cpe-7525	127	3	2019	DATE
cpe-7525	129	1	europe	LOC
cpe-7525	129	2	1(1	CARDINAL
cpe-7525	130	1	m.	PERSON
cpe-7525	130	2	2021	CARDINAL
cpe-7525	131	1	covid-19	PERSON
cpe-7525	132	1	9(2	CARDINAL
cpe-7525	132	2	article 160	LAW
cpe-7525	133	1	https://doi.org/10.3390/vaccines9020160 wake	DATE
cpe-7525	133	2	a. d.	PERSON
cpe-7525	133	3	2021	CARDINAL
cpe-7525	134	1	covid-19	ORG
cpe-7525	135	1	14	CARDINAL
cpe-7525	135	2	2609	CARDINAL
cpe-7525	136	1	europe	LOC
cpe-7525	136	2	the european association of clinical	ORG
cpe-7525	137	1	leibniz institute	ORG
cpe-7525	137	2	germany	GPE
cpe-7525	138	1	europe	LOC
cpe-7525	139	1	6	CARDINAL
cpe-7525	139	2	europe 2021	DATE
cpe-7525	139	3	3(3	CARDINAL